EIN Presswire

LOS ANGELES, CA, UNITED STATES, May 5, 2026 /⁨EINPresswire.com⁩/ -- “Some ACOG members may be less familiar with research indicating that pudendal neuralgia can be associated with soft tissue impacts from mid-urethral slings marketed in the United...

GlobeNewswire, Inc.

Advancing synergistic combination medicines, non-opioid solutions for chronic pain, neuropsychiatric disorders, and substance use disorders using patient-friendly delivery methods.

GlobeNewswire, Inc.

Phase 2 Data Highlight the Observed Abscopal-like Effect of VP-315 in Non-treated Basal Cell Carcinoma Tumors WEST CHESTER, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company...

GlobeNewswire, Inc.

Findings support the Timed Up and Go (TUG) test combined with pain assessment as a promising functional endpoint for evaluating mobility impairment in palmoplantar epidermal differentiation disorders (pEDDs) NESS ZIONA, Israel, May 05, 2026 (GLOBE...

GlobeNewswire, Inc.

-- IMCIVREE® (setmelanotide) launched in the U.S. for acquired hypothalamic obesity; more than 150 patient start forms received in the first six weeks following FDA approval on March 19, 2026 -- -- First quarter 2026 net product revenue from...

GlobeNewswire, Inc.

Q1 2026 net revenues increased 10.0%, or 6.5% on a constant currency basis, compared to Q1 2025 Q1 2026 net income of $27 million or $0.09 per diluted share, compared to a net loss of $13 million or $0.05 per diluted share in Q1 2025 Q1 2026...